Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.

Also called NCT01865474

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 122 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01865474
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Indonesia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01865474. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
DLBS1033
Intervention (Drug)
placebo tablet of DLBS1033
Lead sponsor
Dexa Medica Group (class: industry)

Record details

Record id
cardio:ct-nct01865474
Content hash
d1df4d43ecffa120189fa1b4d7f3fcd995a31c71dfc7cd4cbe409d2a1c17560f